["{\n\"step_by_step_thinking\": \"The question asks what is checked for when using a 95% confidence interval in clinical trials while assessing the efficacy of a newly developed drug in comparison to placebo. The relevant documents discuss the importance of 'assay sensitivity' and illustrate errors that can arise from comparisons finding no difference between experimental and standard treatments. This suggests that the focus is on detecting differences between the new drug and placebo, rather than establishing non-efficacy. Therefore, the correct answer should be related to efficacy.\",\n\"answer_choice\": \"A\"\n}"]